Finance

Lists
688553:SHA
Sichuan Huiyu Pharmaceutical Co Ltd
CNÂ¥10.83
+0.19%
(+0.020) 1D
Oct 16, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688553...
Open
CNÂ¥11.00
High
CNÂ¥11.60
Low
CNÂ¥10.71
Mkt. cap
6.77B
Avg. vol.
11.18M
Volume
16.19M
Dividend
1.25%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 17, 2026
P/E ratio
59.30
52-wk high
CNÂ¥17.33
52-wk low
CNÂ¥9.61
EPS
CNÂ¥0.18
No. of employees
1K
Open
CNÂ¥11.00
High
CNÂ¥11.60
Low
CNÂ¥10.71
Mkt. cap
6.77B
Avg. vol.
11.18M
Volume
16.19M
Dividend
1.25%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 17, 2026
P/E ratio
59.30
52-wk high
CNÂ¥17.33
52-wk low
CNÂ¥9.61
EPS
CNÂ¥0.18
No. of employees
1K
News stories
From web sources and news partners
About Sichuan Huiyu Pharmaceutical Co Ltd
CEO-
Employees1.45K
FoundedOct 12, 2010
Headquarters-
SectorPharmaceutical industry
Websitehuiyupharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
288.63M
256.39M
269.21M
282.65M
Cost of goods sold
51.49M
64.29M
56.06M
76.57M
Cost of revenue
51.49M
64.29M
56.06M
76.57M
Research and development expenses
82.20M
71.08M
66.82M
79.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
121.03M
120.17M
114.36M
103.71M
Operating expense
179.09M
222.65M
172.36M
200.27M
Total operating expenses
230.58M
286.94M
228.42M
276.84M
Operating income
58.05M
-30.54M
40.79M
5.81M
Other non operating income
10.57M
-11.60M
-11.79M
11.36M
EBT including unusual items
28.72M
11.97M
16.51M
32.81M
EBT excluding unusual items
58.75M
-17.76M
46.16M
27.02M
Income tax expense
194.78K
-12.55M
-5.21M
-2.53M
Effective tax rate
0.68%
-104.83%
-31.56%
-7.71%
Other operating expenses
-25.26M
30.82M
-7.90M
12.76M
Net income
29.92M
25.84M
21.87M
35.78M
Net profit margin
10.36%
10.08%
8.12%
12.66%
Earnings per share
-
-
-
-
Interest and investment income
6.63M
21.20M
20.51M
33.47M
Interest expense
-1.41M
-3.11M
-3.35M
-2.82M
Net interest expenses
5.22M
18.09M
17.16M
30.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
77.18M
-8.35M
62.98M
31.35M
Gain or loss from assets sale
-21.34K
-1.89K
-
-4.16K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps